$DVAX
DYNAVAX TECHNOLOGIES CORP

2017 Q1 Form 10-Q Financial Statement

#000156459017009415 Filed on May 08, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q4 2016 Q1
Revenue $148.0K $7.292M $942.0K
YoY Change -84.29% 964.53% 50.24%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.472M $7.450M $7.430M
YoY Change -12.89% 19.58% 71.2%
% of Gross Profit
Research & Development $16.35M $18.44M $20.07M
YoY Change -18.55% -11.9% -9.69%
% of Gross Profit
Depreciation & Amortization $790.0K $690.0K $400.0K
YoY Change 97.5% 68.29% 17.65%
% of Gross Profit
Operating Expenses $25.60M $25.89M $28.24M
YoY Change -9.34% -4.68% 4.27%
Operating Profit -$25.45M -$27.29M
YoY Change -6.75% 3.18%
Interest Expense $150.0K $140.0K $230.0K
YoY Change -34.78% 7.69% -6.88%
% of Operating Profit
Other Income/Expense, Net $20.00K -$2.560M $46.00K
YoY Change -56.52% 6300.0% -89.89%
Pretax Income -$25.29M -$21.74M -$27.02M
YoY Change -6.4% -19.06% 3.05%
Income Tax
% Of Pretax Income
Net Earnings -$25.29M -$21.74M -$27.02M
YoY Change -6.42% -19.06% 3.07%
Net Earnings / Revenue -17085.81% -298.15% -2868.68%
Basic Earnings Per Share
Diluted Earnings Per Share -$604.6K -$563.9K -$702.4K
COMMON SHARES
Basic Shares Outstanding 44.35M 38.53M
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q1 2016 Q4 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $85.40M $81.40M $166.8M
YoY Change -48.8% -58.5% 70.9%
Cash & Equivalents $21.47M $24.29M $38.86M
Short-Term Investments $63.90M $57.10M $128.0M
Other Short-Term Assets $2.800M $6.800M $2.700M
YoY Change 3.7% 183.33% -22.86%
Inventory
Prepaid Expenses
Receivables $1.500M $1.300M $1.200M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $89.70M $89.60M $170.7M
YoY Change -47.45% -55.19% 67.35%
LONG-TERM ASSETS
Property, Plant & Equipment $16.60M $17.17M $15.90M
YoY Change 4.4% 24.41% 112.0%
Goodwill $1.971M
YoY Change -3.52%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.800M $334.0K $900.0K
YoY Change 100.0% 44.59% 50.0%
Total Long-Term Assets $20.40M $20.08M $18.90M
YoY Change 7.94% 20.34% 85.29%
TOTAL ASSETS
Total Short-Term Assets $89.70M $89.60M $170.7M
Total Long-Term Assets $20.40M $20.08M $18.90M
Total Assets $110.1M $109.7M $189.6M
YoY Change -41.93% -49.37% 68.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.500M $3.796M $3.500M
YoY Change -57.14% 10.57% 6.06%
Accrued Expenses $10.90M $11.19M $19.30M
YoY Change -43.52% -27.03% 77.06%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.40M $20.00M $24.50M
YoY Change -49.39% -30.56% 19.51%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $358.0K $443.0K $700.0K
YoY Change -48.86% -44.63% -90.91%
Total Long-Term Liabilities $358.0K $443.0K $700.0K
YoY Change -48.86% -44.63% -95.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.40M $20.00M $24.50M
Total Long-Term Liabilities $358.0K $443.0K $700.0K
Total Liabilities $12.74M $20.48M $25.20M
YoY Change -49.46% -30.81% -32.08%
SHAREHOLDERS EQUITY
Retained Earnings -$837.5M -$812.2M -$726.8M
YoY Change 15.23% 16.07%
Common Stock $938.2M $905.0M $893.3M
YoY Change 5.03% 1.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $97.40M $89.20M $164.4M
YoY Change
Total Liabilities & Shareholders Equity $110.1M $109.7M $189.6M
YoY Change -41.93% -49.37% 69.02%

Cashflow Statement

Concept 2017 Q1 2016 Q4 2016 Q1
OPERATING ACTIVITIES
Net Income -$25.29M -$21.74M -$27.02M
YoY Change -6.42% -19.06% 3.07%
Depreciation, Depletion And Amortization $790.0K $690.0K $400.0K
YoY Change 97.5% 68.29% 17.65%
Cash From Operating Activities -$25.25M -$26.28M -$27.13M
YoY Change -6.93% 20.27% 12.39%
INVESTING ACTIVITIES
Capital Expenditures $234.0K -$1.240M $2.611M
YoY Change -91.04% -54.41% 322.49%
Acquisitions
YoY Change
Other Investing Activities -$6.780M $29.37M $23.36M
YoY Change -129.02% -186.82% -335.96%
Cash From Investing Activities -$7.010M $28.12M $20.75M
YoY Change -133.78% -176.91% -297.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $29.54M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 29.39M -220.0K 340.0K
YoY Change 8544.12% -173.33% 142.86%
NET CHANGE
Cash From Operating Activities -25.25M -26.28M -27.13M
Cash From Investing Activities -7.010M 28.12M 20.75M
Cash From Financing Activities 29.39M -220.0K 340.0K
Net Change In Cash -2.814M 1.620M -6.040M
YoY Change -53.41% -102.79% -82.5%
FREE CASH FLOW
Cash From Operating Activities -$25.25M -$26.28M -$27.13M
Capital Expenditures $234.0K -$1.240M $2.611M
Free Cash Flow -$25.48M -$25.04M -$29.74M
YoY Change -14.31% 30.89% 20.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 us-gaap License And Services Revenue
LicenseAndServicesRevenue
8000
CY2017Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
938159000
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45448022
CY2017Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3350000
CY2017Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
45000
CY2017Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-837458000
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
110132000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
109680000
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
69500000
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45448000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38599000
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
39000
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3624000
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
97396000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
89201000
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
69500000
CY2017Q1 us-gaap Revenue From Grants
RevenueFromGrants
148000
CY2017Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
358000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
443000
CY2017Q1 us-gaap Liabilities
Liabilities
12736000
CY2016Q4 us-gaap Liabilities
Liabilities
20479000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-812171000
CY2016Q1 us-gaap Revenue From Grants
RevenueFromGrants
39000
CY2016Q1 us-gaap Contracts Revenue
ContractsRevenue
895000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
904957000
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38599000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-25287000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-27023000
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25013000
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26228000
CY2017Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
789000
CY2016Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
402000
CY2017Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
21000
CY2017Q1 us-gaap Revenues
Revenues
148000
CY2016Q1 us-gaap Revenues
Revenues
942000
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16345000
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20067000
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6472000
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8169000
CY2017Q1 us-gaap Restructuring Charges
RestructuringCharges
2783000
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
25600000
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
28236000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-25452000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-27294000
CY2017Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
145000
CY2016Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
225000
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20000
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
46000
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.60
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.70
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
41830000
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38472000
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-29000
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
109000
CY2017Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
303000
CY2016Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
686000
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
274000
CY2016Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
795000
CY2017Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
10000
CY2016Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-75000
CY2016Q1 dvax Cash Settled Portion Of Stock Based Compensation Expense
CashSettledPortionOfStockBasedCompensationExpense
328000
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3821000
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3244000
CY2017Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
123000
CY2016Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-230000
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
39000
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
301000
CY2017Q1 dvax Increase Decrease In Restricted Cash And Other Assets For Operating Activities
IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities
907000
CY2016Q1 dvax Increase Decrease In Restricted Cash And Other Assets For Operating Activities
IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities
36000
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2110000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
658000
CY2017Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1363000
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3816000
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-895000
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-25250000
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-27134000
CY2017Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
44652000
CY2016Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
61057000
CY2017Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
37875000
CY2016Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
84420000
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
234000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38858000
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2611000
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-7011000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
20752000
CY2017Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
29535000
CY2017Q1 dvax Tax Withholdings Proceeds From Exercise Of Stock Options And Restricted Stock Awards Net
TaxWithholdingsProceedsFromExerciseOfStockOptionsAndRestrictedStockAwardsNet
-303000
CY2016Q1 dvax Tax Withholdings Proceeds From Exercise Of Stock Options And Restricted Stock Awards Net
TaxWithholdingsProceedsFromExerciseOfStockOptionsAndRestrictedStockAwardsNet
75000
CY2017Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
155000
CY2016Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
261000
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
29387000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
336000
CY2017Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
57000
CY2016Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
92000
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2817000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5954000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44812000
CY2017Q1 dvax Release Of Accrual For Litigation Settlement And Insurance Recovery
ReleaseOfAccrualForLitigationSettlementAndInsuranceRecovery
4050000
CY2016Q1 dvax Supplemental Disposal Of Assets
SupplementalDisposalOfAssets
1154000
CY2017Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of financial statements in conformity with GAAP requires management to make informed estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Management&#8217;s estimates are based on historical information available as of the date of the condensed consolidated financial statements and various other assumptions we believe are reasonable under the circumstances. Actual results could differ materially from these estimates.</p></div>
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
8000
CY2017Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
600000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4000
CY2017Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
85356000
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
81415000
CY2016Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000
CY2017Q1 us-gaap Deferred Rent Credit
DeferredRentCredit
300000
CY2016Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
300000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
1930000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1498000
CY2017Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2017Q1 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.40
CY2017Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
85400000
CY2017Q1 us-gaap Fair Value Equity Level1 To Level2 Transfers Amount
FairValueEquityLevel1ToLevel2TransfersAmount
0
CY2017Q1 us-gaap Fair Value Equity Level2 To Level1 Transfers Amount
FairValueEquityLevel2ToLevel1TransfersAmount
0
CY2017Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
85382000
CY2016Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
81411000
CY2017Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3000
CY2017Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
29000
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
63909000
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
0
CY2017Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
63909000
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
63884000
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
0
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
63884000
CY2017Q1 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0
CY2016Q1 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
645000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
650000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
522000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
570000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
5815000
CY2017Q1 us-gaap Loss Contingency Settlement Agreement Date
LossContingencySettlementAgreementDate
September 7, 2016
CY2017Q1 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2016Q1 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
155000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3799000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3785000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2181000
CY2016Q4 dvax Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Weighted Average Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice
21.38
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.24
CY2017Q1 dvax Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Weighted Average Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice
20.65
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
20.67
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
22.93
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y1M28D
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y1M24D
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y4M28D
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3975000
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
19000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
42000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
42000
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3821000
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3244000

Files In Submission

Name View Source Status
0001564590-17-009415-index-headers.html Edgar Link pending
0001564590-17-009415-index.html Edgar Link pending
0001564590-17-009415.txt Edgar Link pending
0001564590-17-009415-xbrl.zip Edgar Link pending
dvax-10q_20170331.htm Edgar Link pending
dvax-20170331.xml Edgar Link completed
dvax-20170331.xsd Edgar Link pending
dvax-20170331_cal.xml Edgar Link unprocessable
dvax-20170331_def.xml Edgar Link unprocessable
dvax-20170331_lab.xml Edgar Link unprocessable
dvax-20170331_pre.xml Edgar Link unprocessable
dvax-ex311_7.htm Edgar Link pending
dvax-ex312_8.htm Edgar Link pending
dvax-ex321_6.htm Edgar Link pending
dvax-ex322_9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending